DOCSLIB.ORG

LINC00963 Predicts Poor Prognosis and Promotes Esophageal Cancer Cells Invasion Via Targeting Mir-214-5P/RAB14 Axis H.-F

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
LINC00963 Predicts Poor Prognosis and Promotes Esophageal Cancer Cells Invasion Via Targeting Mir-214-5P/RAB14 Axis H.-F European Review for Medical and Pharmacological Sciences 2020; 24: 164-173 LINC00963 predicts poor prognosis and promotes esophageal cancer cells invasion via targeting miR-214-5p/RAB14 axis H.-F. LIU1, Q. ZHEN2, Y.-K. FAN3 1Department of Gastroenterology, The First Hospital of Shijiazhuang City, Shijiazhuang, Hebei, China 2Department of Thoracic Surgery, The First Hospital of Shijiazhuang City, Shijiazhuang, Hebei, China 3Department of Geriatrics, The First Hospital of Shijiazhuang City, Shijiazhuang, Hebei, China Abstract. – OBJECTIVE: To explore the roles Long non-coding RNAs (lncRNAs) are RNA and underlying mechanism of LINC00963 in molecules over 200 nucleotides without capacity esophageal squamous cell carcinoma (ESCC) to encode protein6. Recently, accumulating evi- progression. 7-9 PATIENTS AND METHODS: dence suggested that lncRNAs play important Quantitative Re- roles in tumor procession, including ESCC pro- al Time-PCR (qRT-PCR) was used to detect 10 LINC00963 expression in ESCC tissues. EdU, col- gression. Wu et al showed that CASC9 promoted ony formation, and transwell invasion assays were ESCC growth via suppressing PDCD4 expression used to detect the proliferation and metastasis abil- by regulating EZH2. Chen et al11 suggested that ity of ESCC, respectively. The correlation between lncRNA FAM201A mediated the radio-sensitivity LINC00963 and miR-214-5p in ESCC was confirmed of ESCC via regulating the miR-101/ATM/mTOR by a Luciferase reporter and RIP assays. axis. Yang et al12 revealed that lncRNA FTH1P3 RESULTS: LINC00963 expression was signifi- cantly increased in ESCC tissues and correlat- promoted ESCC cells proliferation and metastasis ed with advanced TNM stage, metastasis, and by regulating SP1/NF-kB axis. poor prognosis. The knockdown of LINC00963 LINC00963 is located in chromosome 9, which expression reduced ESCC cells proliferation, has been reported to play critical roles in tumor invasion in vitro, and reduced tumor growth progression. Wang et al13 showed that LINC00963 in vivo. In mechanism, LINC00963 served as a was involved in prostate cancer metastasis by reg- sponge for miR-214-5p in ESCC progression. In 14 addition, miR-214-5p could bind to RAB14 and ulating EGFR expression. Wu et al suggested regulate its expression. that LINC00963 promoted hepatocellular carci- CONCLUSIONS: LINC00963 might promote ES- noma cells proliferation by activating the PI3K/ CC cells proliferation and invasion via regulating AKT axis. Yu et al15 found that LINC00963 pro- the miR-214-5p/RAB14 axis and it might serve as moted lung cancer metastasis by regulating the a therapeutic target for ESCC treatment. PGK1/AKT/mTOR axis. However, the role and Key Words: underlying mechanism of LINC00963 in ESCC LINC00963, MiR-214-5p, RAB14, Esophageal squa- progression remain unclear. mous cell carcinoma. In the present study, we found that LINC00963 could act as an oncogenic lncRNA in ESCC pro- gression. In mechanism, LINC00963 promoted ESCC progression by sponging miR-214-5p and Introduction upregulating RAB14 expression. These data sug- gested that LINC00963 might act as a potential Esophageal cancer (EC) is one of the most therapeutic treatment in ESCC. common cancers worldwide1. According to its biological characteristics, EC categorized into esophageal adenocarcinoma and esophageal Patients and Methods squamous cell carcinoma (ESCC)2,3. Although the great advanced treatments in ESCC, the 5-year Tissue Specimens overall survival rates remain poor4,5. Therefore, A total of 54 ESCC tissues were collected from it is imperative to explore the molecular mecha- patients who underwent surgical resection at the nisms of ESCC and develop novel therapeutic tar- First Hospital of Shijiazhuang City. No patients gets for tumor treatment. received chemotherapy or radiotherapy before 164 Corresponding Author: Qiang Zhen, MD; e-mail: [email protected] LINC00963/miR-214-5p/RAB14 axis in ESCC surgery. All ESCC specimens were confirmed by Western Blot experienced pathologists. The investigation was Cells were lysed using Radio Immunoprecip- approved by the Ethics Committee of The First itation Assay (RIPA) lysis (Beyotime, Shanghai, Hospital of Shijiazhuang City. Written informed China) containing protease inhibitors. The cell consents were provided by all participants. lysates were separated by sodium dodecyl sul- phate-polyacrylamide gel electrophoresis (SDS- Cell Culture and Transfection PAGE) and transferred onto polyvinylidene diflu- Human ESCC cell lines (TE-1, ECA-109, TE- oride (PVDF) membranes (Millipore, Billerica, 13, EC9706, and KYSE-150) and normal esopha- MA, USA), which were blocked by blocking solu- geal epithelial cell line (HET-1A) were obtained tion containing 5% skim milk powder at room from Shanghai Institutes for Biological Science temperature for 2 h. The PVDF membranes were (Shanghai, China). All cells were grown in Dul- incubated with primary antibodies overnight, becco’s Modified Eagle’s Medium (DMEM) con- which were then incubated with secondary anti- taining 10% fetal bovine serum (FBS; Gibco, bodies at room temperature for 2 h. Rockville, MD, USA) at 37°C in a humidified 5% CO2 incubator. Luciferase Reporter Assay MiR-214-5p mimics, miR-214-5p inhibitors, Based on pmirGLO vectors (Promega, Mad- and sh-LINC00963 were obtained from Gene- ison, WI, USA), the 3’ UTR of LINC00963 or Pharma (Shanghai, China). All plasmids were RAB14 with miR-214-5p binding sites or mutant transfected into cells using Lipofectamine 2000 sites was used to generate wild type (WT) or mu- reagents (Invitrogen, Carlsbad, CA, USA). tant (MUT) Luciferase reporter vectors, named as LINC00963-Wt, LINC00963-Mut, RAB14-Wt RNA Isolation and QRT-PCR or RAB14-Mut, respectively. MiR-214-5p mimics The total RNAs from tissues or cells were or miR-NC was co-transfected with LINC00963- extracted using TRIzol reagents (Invitrogen, Wt, LINC00963-Mut, RAB14-Wt or RAB14-Mut Carlsbad, CA, USA). The reverse transcription into HEK293T cells using Lipofectamine 2000 was performed with 25 μL system based on the reagents (Invitrogen, Carlsbad, CA, USA). Cells instructions of the cDNA reverse transcription were collected at 48 h after the transfection and kit (TaKaRa, Otsu, Shiga, Japan). The obtained the relative luciferase activity was detected using cDNA was diluted to 50 ng/μL for the following a luciferase reporter assay kit (Promega, Madi- Real time-PCR, which was carried out on the flu- son, WI, USA). orescence quantitative polymerase chain reaction instrument. The fold changes were calculated by RNA Immunoprecipitation (RIP) Assay the 2-ΔΔCt method. Glyceraldehyde 3-phosphate RIP analysis was described as the previous dehydrogenase (GAPDH) and U6 were severed as study16. Briefly, cells were lysed with RIP-lysis the internal controls, respectively. buffer. The cell lysate was collected and incubat- ed with the magnetic beads that were conjugat- Cell Proliferation Assay ed with an anti-Argonaute 2 (AGO2) or negative EdU cell proliferation assay was determined control IgG antibodies (Millipore, Billerica, MA, as previously described10. For colony formation USA), treated with proteinase K to digest the pro- assay, cells were plated into 24-well plates (2×104 teins, and was subjected to RNA extraction us- cells/well) and incubated at 37°C for 10 days. ing the TRIzol® reagent. The immunoprecipitated Cells were then fixed with 4% paraformaldehyde RNA was analyzed by RT-qPCR. and stained with 0.05% crystal violet. The visible colonies were counted. Xenograft Mouse Model 5 weeks old BALB/c nude mice were obtained Transwell Assay from Shanghai SLAC Laboratory Animal (Shang- Transfected cells were plated into the upper hai, China). Transfected KYSE-150 cells (1×106) chamber of 24-well plates with Matrigel-coated were subcutaneously inoculated into the right flank membrane. The bottom chamber was filled with of the nude mice. Tumor volume was measured ev- DMEM medium supplemented with 20% FBS. ery 7 days for 42 days and calculated according Cells were incubated for 48 h. Next, the invaded to the equation: V = (length × width2)/2. All mice cells were fixed with 4 % paraformaldehyde and were sacrificed at day 42 of inoculation, and the stained with crystal violet dye. tumor weight was measured. Mice were bred in the 165 H.-F. Liu, Q. Zhen, Y.-K. Fan Animal Core Facility by following procedures ap- Results proved by Animal Ethics Committee in The First Hospital of Shijiazhuang City. LINC00963 was upregulated in ESCC We first determined LINC00963 expression Statistical Analysis in ESCC tissues and adjacent non-tumor tissues Data were displayed as mean ± standard devi- (NC). Results showed that LINC00963 expression ation (SD) from three separate experiments. SPSS was upregulated in ESCC tissues (Figure 1A). 21.0 (IBM, Armonk, NY, USA) was selected for Subsequently, high expression of LINC00963 was statistical analysis. The comparisons of the two associated with advanced TNM stage and lymph- groups or multiple groups were performed using node metastasis in ESCC patients (Figure 1B and the Student’s t-test or One-way ANOVA. p < 0.05 1C). GEPIA database showed that LINC00963 was considered as statistically significant. was upregulated in ESCC tissues (Figure 1D). A B C E D F G Figure 1. LINC00963 was highly expressed in ESCC. A, LINC00963 expression was upregulated in ESCC tissues compared to adjacent non-tumor tissues (NC). B-C, High LINC00963 expression was associated with advanced TNM stage, and lymph- node metastasis in ESCC patients. D, GEPIA showed that LINC00963 was upregulated in ESCC tissues. E, LINC00963 ex- pression was decreased in esophageal tissues by GTEx database. F, G, High LINC00963 expression was associated with poor overall survival and disease-free survival in ESCC patients. *p<0.05 166 LINC00963/miR-214-5p/RAB14 axis in ESCC A B C D E F Figure 2. LINC00963 inhibition reduced ESCC cells proliferation abilities. A, LINC00963 expression was upregulated in ESCC cell lines. B, Sh-LINC00963 decreased LINC00963 expression in KYSE-150 and TE-1 cells. C-D, LINC00963 sup- pression reduced KYSE-150 and TE-1 cells proliferation abilities (magnification, ×200). E, F, LINC00963 inhibition decreased KYSE-150 and TE-1 cells colony numbers (magnification, ×200).
Load more

Recommended publications
  • Exosomes from Nischarin-Expressing Cells Reduce Breast Cancer Cell Motility and Tumor Growth
    Author Manuscript Published OnlineFirst on January 11, 2019; DOI: 10.1158/0008-5472.CAN-18-0842 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Exosomes from Nischarin-Expressing Cells Reduce Breast Cancer Cell Motility and tumor growth Mazvita Maziveyi1,7, Shengli Dong1, Somesh Baranwal2, Ali Mehrnezhad3, Rajamani Rathinam4, Thomas M. Huckaba5, Donald E. Mercante6, Kidong Park3, Suresh K. Alahari1 1Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, LA, USA 2Center of Biochemistry and Microbial Science, Central University of Punjab, Bathinda-151001, India 3Department of Electrical Engineering and Computer Engineering, Louisiana State University, Baton Rouge, LA, USA 4Wayne State University, Detroit, MI, USA 5Department of Biology, Xavier University of Louisiana, New Orleans, LA, USA 6School of Public Health, LSUHSC School of Medicine, New Orleans, LA, USA 7Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas *Corresponding author; Suresh K. Alahari, PhD; Fred G. Brazda Professor of Biochemistry, LSUHSC School of Medicine, New Orleans, LA 70112, USA; Tel: 504-568-4734 [email protected] Running Title: Nischarin regulates exosome production Conflicts of Interest No potential conflicts of interest were disclosed. Downloaded from cancerres.aacrjournals.org on September 29, 2021. © 2019 American Association for Cancer Research. Author Manuscript Published OnlineFirst on January 11, 2019; DOI: 10.1158/0008-5472.CAN-18-0842 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Abstract: Exosomes are small extracellular microvesicles that are secreted by cells when intracellular multivesicular bodies (MVB) fuse with the plasma membrane.
    [Show full text]
  • Breast Cancer Tumor Suppressors: a Special Emphasis on Novel Protein Nischarin Mazvita Maziveyi and Suresh K
    Published OnlineFirst September 21, 2015; DOI: 10.1158/0008-5472.CAN-15-1395 Cancer Review Research Breast Cancer Tumor Suppressors: A Special Emphasis on Novel Protein Nischarin Mazvita Maziveyi and Suresh K. Alahari Abstract Tumor suppressor genes regulate cell growth and prevent vast number of cellular processes, including neuronal protection spontaneous proliferation that could lead to aberrant tissue and hypotension. The NISCH promoter experiences hypermethy- function. Deletions and mutations of these genes typically lead lation in several cancers, whereas some highly aggressive breast to progression through the cell-cycle checkpoints, as well as cancer cells exhibit genomic loss of the NISCH locus. Further- increased cell migration. Studies of these proteins are important more, we discuss data illustrating a novel role of Nischarin as as they may provide potential treatments for breast cancers. In this a tumor suppressor in breast cancer. Analysis of this new para- review, we discuss a comprehensive overview on Nischarin, a digm may shed light on various clinical questions. Finally, the novel protein discovered by our laboratory. Nischarin, or imida- therapeutic potential of Nischarin is discussed. Cancer Res; 75(20); zoline receptor antisera-selected protein, is a protein involved in a 4252–9. Ó2015 AACR. Introduction (6, 7). It also interacts with LIM kinase (LIMK) in order to prevent cytoskeletal reorganization (8). Typically, scaffold proteins such Breast cancer initiation and progression involve several genetic as Nischarin are characterized as caretaker genes because their events that can activate oncogenes and/or abrogate the function of effects on tumor growth are indirect. tumor suppressor genes. Tumor suppressor genes are commonly lost or deleted in cancers, facilitating the initiation and progres- sion of cancer through several biological events, including cell Discovery of Nischarin proliferation, cell death, cell migration, and cell invasion.
    [Show full text]
  • Aneuploidy: Using Genetic Instability to Preserve a Haploid Genome?
    Health Science Campus FINAL APPROVAL OF DISSERTATION Doctor of Philosophy in Biomedical Science (Cancer Biology) Aneuploidy: Using genetic instability to preserve a haploid genome? Submitted by: Ramona Ramdath In partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biomedical Science Examination Committee Signature/Date Major Advisor: David Allison, M.D., Ph.D. Academic James Trempe, Ph.D. Advisory Committee: David Giovanucci, Ph.D. Randall Ruch, Ph.D. Ronald Mellgren, Ph.D. Senior Associate Dean College of Graduate Studies Michael S. Bisesi, Ph.D. Date of Defense: April 10, 2009 Aneuploidy: Using genetic instability to preserve a haploid genome? Ramona Ramdath University of Toledo, Health Science Campus 2009 Dedication I dedicate this dissertation to my grandfather who died of lung cancer two years ago, but who always instilled in us the value and importance of education. And to my mom and sister, both of whom have been pillars of support and stimulating conversations. To my sister, Rehanna, especially- I hope this inspires you to achieve all that you want to in life, academically and otherwise. ii Acknowledgements As we go through these academic journeys, there are so many along the way that make an impact not only on our work, but on our lives as well, and I would like to say a heartfelt thank you to all of those people: My Committee members- Dr. James Trempe, Dr. David Giovanucchi, Dr. Ronald Mellgren and Dr. Randall Ruch for their guidance, suggestions, support and confidence in me. My major advisor- Dr. David Allison, for his constructive criticism and positive reinforcement.
    [Show full text]
  • Identification of Candidate Genes and Pathways Associated with Obesity
    animals Article Identification of Candidate Genes and Pathways Associated with Obesity-Related Traits in Canines via Gene-Set Enrichment and Pathway-Based GWAS Analysis Sunirmal Sheet y, Srikanth Krishnamoorthy y , Jihye Cha, Soyoung Choi and Bong-Hwan Choi * Animal Genome & Bioinformatics, National Institute of Animal Science, RDA, Wanju 55365, Korea; [email protected] (S.S.); [email protected] (S.K.); [email protected] (J.C.); [email protected] (S.C.) * Correspondence: [email protected]; Tel.: +82-10-8143-5164 These authors contributed equally. y Received: 10 October 2020; Accepted: 6 November 2020; Published: 9 November 2020 Simple Summary: Obesity is a serious health issue and is increasing at an alarming rate in several dog breeds, but there is limited information on the genetic mechanism underlying it. Moreover, there have been very few reports on genetic markers associated with canine obesity. These studies were limited to the use of a single breed in the association study. In this study, we have performed a GWAS and supplemented it with gene-set enrichment and pathway-based analyses to identify causative loci and genes associated with canine obesity in 18 different dog breeds. From the GWAS, the significant markers associated with obesity-related traits including body weight (CACNA1B, C22orf39, U6, MYH14, PTPN2, SEH1L) and blood sugar (PRSS55, GRIK2), were identified. Furthermore, the gene-set enrichment and pathway-based analysis (GESA) highlighted five enriched pathways (Wnt signaling pathway, adherens junction, pathways in cancer, axon guidance, and insulin secretion) and seven GO terms (fat cell differentiation, calcium ion binding, cytoplasm, nucleus, phospholipid transport, central nervous system development, and cell surface) which were found to be shared among all the traits.
    [Show full text]
  • File Download
    Nischarin inhibition alters energy metabolism by activating AMP-activated protein kinase Shengli Dong, Louisiana State University Somesh Baranwal, Louisiana State University AnaPatricia Garcia, Emory University Silvia J. Serrano-Gomez, Louisiana State University Steven Eastlack, Louisiana State University Tomoo Iwakuma, Kansas University Medical Center Donald Mercante, Louisiana State University Franck Mauvais-Jarvis, Tulane University School of Medicine Suresh K. Alahari, Louisiana State University Journal Title: Journal of Biological Chemistry Volume: Volume 292, Number 41 Publisher: American Society for Biochemistry and Molecular Biology | 2017-10-13, Pages 16833-16846 Type of Work: Article | Final Publisher PDF Publisher DOI: 10.1074/jbc.M117.784256 Permanent URL: https://pid.emory.edu/ark:/25593/tdw0b Final published version: http://dx.doi.org/10.1074/jbc.M117.784256 Copyright information: © 2017 by The American Society for Biochemistry and Molecular Biology, Inc. Accessed October 1, 2021 8:18 PM EDT ARTICLE cro Nischarin inhibition alters energy metabolism by activating AMP-activated protein kinase Received for publication, March 2, 2017, and in revised form, August 22, 2017 Published, Papers in Press, August 24, 2017, DOI 10.1074/jbc.M117.784256 Shengli Dong‡, Somesh Baranwal‡§, Anapatricia Garcia¶, Silvia J. Serrano-Gomez‡ʈ, Steven Eastlack‡, Tomoo Iwakuma**, Donald Mercante‡‡, Franck Mauvais-Jarvis§§1, and Suresh K. Alahari‡2 From the ‡Department of Biochemistry and Molecular Biology, School of Medicine, and ‡‡Department of Biostatistics,
    [Show full text]
  • Mouse Rab14 Conditional Knockout Project (CRISPR/Cas9)
    https://www.alphaknockout.com Mouse Rab14 Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Rab14 conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Rab14 gene (NCBI Reference Sequence: NM_026697 ; Ensembl: ENSMUSG00000026878 ) is located on Mouse chromosome 2. 8 exons are identified, with the ATG start codon in exon 2 and the TAG stop codon in exon 8 (Transcript: ENSMUST00000028238). Exon 3~4 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Rab14 gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP23-198N5 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Exon 3 starts from about 8.22% of the coding region. The knockout of Exon 3~4 will result in frameshift of the gene. The size of intron 2 for 5'-loxP site insertion: 1055 bp, and the size of intron 4 for 3'-loxP site insertion: 3159 bp. The size of effective cKO region: ~2166 bp. The cKO region does not have any other known gene. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 2 3 4 8 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Rab14 Homology arm cKO region loxP site Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats.
    [Show full text]
  • Exosomes from Nischarin-Expressing Cells Reduce Breast Cancer Cell Motility and Tumor Growth
    Published OnlineFirst January 11, 2019; DOI: 10.1158/0008-5472.CAN-18-0842 Cancer Molecular Cell Biology Research Exosomes from Nischarin-Expressing Cells Reduce Breast Cancer Cell Motility and Tumor Growth Mazvita Maziveyi1, Shengli Dong1, Somesh Baranwal2, Ali Mehrnezhad3, Rajamani Rathinam4, Thomas M. Huckaba5, Donald E. Mercante6, Kidong Park3, and Suresh K. Alahari1 Abstract Exosomes are small extracellular microvesicles that are secre- secreted by Nischarin-expressing tumors inhibited tumor ted by cells when intracellular multivesicular bodies fuse with growth. Expression of only one allele of Nischarin increased the plasma membrane. We have previously demonstrated that secretion of exosomes, and Rab14 activity modulated exosome Nischarin inhibits focal adhesion formation, cell migration, secretions and cell growth. Taken together, this study reveals a and invasion, leading to reduced activation of focal adhesion novel role for Nischarin in preventing cancer cell motility, kinase. In this study, we propose that the tumor suppressor which contributes to our understanding of exosome biology. Nischarin regulates the release of exosomes. When cocultured on exosomes from Nischarin-positive cells, breast cancer cells Significance: Regulation of Nischarin-mediated exosome exhibited reduced survival, migration, adhesion, and spread- secretion by Rab14 seems to play an important role in con- ing. The same cocultures formed xenograft tumors of signifi- trolling tumor growth and migration. cantly reduced volume following injection into mice. Exosomes See related commentary by McAndrews and Kalluri, p. 2099 Introduction rins to attach to extracellular matrix (ECM) proteins (6, 7). Each Nischarin, or imidazoline receptor antisera-selected (IRAS) integrin has designated ligand(s), and decreased expression of protein, is a protein involved in a number of biological processes.
    [Show full text]
  • Changes in Prostate Gene Expression in Men Undergoing an Intensive Nutrition and Lifestyle Intervention
    Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention Dean Ornish*†‡, Mark Jesus M. Magbanua§, Gerdi Weidner*, Vivian Weinberg¶, Colleen Kemp*, Christopher Green§, Michael D. Mattie§, Ruth Marlin*, Jeff Simkoʈ, Katsuto Shinohara§, Christopher M. Haqq§ and Peter R. Carroll§ §Department of Urology, The Helen Diller Family Comprehensive Cancer Center, and ʈDepartment of Pathology, University of California, 2340 Sutter Street, San Francisco, CA 94115; *Preventive Medicine Research Institute, 900 Bridgeway, Sausalito, CA 94965; †Department of Medicine, School of Medicine, University of California, 505 Parnassus Avenue, San Francisco, CA 94143; and ¶Biostatistics Core, The Helen Diller Family Comprehensive Cancer Center, University of California, 513 Parnassus Avenue, Box 0127, San Francisco, CA 94143 Communicated by J. Craig Venter, The J. Craig Venter Institute, Rockville, MD, April 2, 2008 (received for review February 13, 2008) Epidemiological and prospective studies indicate that comprehensive indolent low-risk prostate cancers, defined by strict clinical and lifestyle changes may modify the progression of prostate cancer. pathologic criteria designed to minimize the risk for metastatic However, the molecular mechanisms by which improvements in diet disease as a result of study participation (9). The 30 men who and lifestyle might affect the prostate microenvironment are poorly enrolled did not undergo surgery or radiation therapy to treat their understood. We conducted a pilot study to examine changes in low-risk tumors; rather, they underwent comprehensive lifestyle prostate gene expression in a unique population of men with low-risk changes (low-fat, whole-foods, plant-based nutrition; stress man- prostate cancer who declined immediate surgery, hormonal therapy, agement techniques; moderate exercise; and participation in a or radiation and participated in an intensive nutrition and lifestyle psychosocial group support).
    [Show full text]
  • Downloaded, Each with Over 20 Samples for AD-Specific Pathways, Biological Processes, and Driver Each Specific Brain Region in Each Condition
    Xiang et al. BMC Medical Genomics 2018, 11(Suppl 6):115 https://doi.org/10.1186/s12920-018-0431-1 RESEARCH Open Access Condition-specific gene co-expression network mining identifies key pathways and regulators in the brain tissue of Alzheimer’s disease patients Shunian Xiang1,2, Zhi Huang4, Wang Tianfu1, Zhi Han3, Christina Y. Yu3,5, Dong Ni1*, Kun Huang3* and Jie Zhang2* From 29th International Conference on Genome Informatics Yunnan, China. 3-5 December 2018 Abstract Background: Gene co-expression network (GCN) mining is a systematic approach to efficiently identify novel disease pathways, predict novel gene functions and search for potential disease biomarkers. However, few studies have systematically identified GCNs in multiple brain transcriptomic data of Alzheimer’s disease (AD) patients and looked for their specific functions. Methods: In this study, we first mined GCN modules from AD and normal brain samples in multiple datasets respectively; then identified gene modules that are specific to AD or normal samples; lastly, condition-specific modules with similar functional enrichments were merged and enriched differentially expressed upstream transcription factors were further examined for the AD/normal-specific modules. Results: We obtained 30 AD-specific modules which showed gain of correlation in AD samples and 31 normal- specific modules with loss of correlation in AD samples compared to normal ones, using the network mining tool lmQCM. Functional and pathway enrichment analysis not only confirmed known gene functional categories related to AD, but also identified novel regulatory factors and pathways. Remarkably, pathway analysis suggested that a variety of viral, bacteria, and parasitic infection pathways are activated in AD samples.
    [Show full text]
  • A SARS-Cov-2 Protein Interaction Map Reveals Targets for Drug Repurposing
    Article A SARS-CoV-2 protein interaction map reveals targets for drug repurposing https://doi.org/10.1038/s41586-020-2286-9 A list of authors and affiliations appears at the end of the paper Received: 23 March 2020 Accepted: 22 April 2020 A newly described coronavirus named severe acute respiratory syndrome Published online: 30 April 2020 coronavirus 2 (SARS-CoV-2), which is the causative agent of coronavirus disease 2019 (COVID-19), has infected over 2.3 million people, led to the death of more than Check for updates 160,000 individuals and caused worldwide social and economic disruption1,2. There are no antiviral drugs with proven clinical efcacy for the treatment of COVID-19, nor are there any vaccines that prevent infection with SARS-CoV-2, and eforts to develop drugs and vaccines are hampered by the limited knowledge of the molecular details of how SARS-CoV-2 infects cells. Here we cloned, tagged and expressed 26 of the 29 SARS-CoV-2 proteins in human cells and identifed the human proteins that physically associated with each of the SARS-CoV-2 proteins using afnity-purifcation mass spectrometry, identifying 332 high-confdence protein–protein interactions between SARS-CoV-2 and human proteins. Among these, we identify 66 druggable human proteins or host factors targeted by 69 compounds (of which, 29 drugs are approved by the US Food and Drug Administration, 12 are in clinical trials and 28 are preclinical compounds). We screened a subset of these in multiple viral assays and found two sets of pharmacological agents that displayed antiviral activity: inhibitors of mRNA translation and predicted regulators of the sigma-1 and sigma-2 receptors.
    [Show full text]
  • Activity in Primary Mammary Tumors Role for Wnt-Signaling in Mediating
    Downloaded from http://www.jimmunol.org/ by guest on October 2, 2021 is online at: average * The Journal of Immunology , 25 of which you can access for free at: 2010; 184:702-712; Prepublished online 16 from submission to initial decision 4 weeks from acceptance to publication December 2009; doi: 10.4049/jimmunol.0902360 http://www.jimmunol.org/content/184/2/702 Gene Expression Analysis of Macrophages That Facilitate Tumor Invasion Supports a Role for Wnt-Signaling in Mediating Their Activity in Primary Mammary Tumors Laureen S. Ojalvo, Charles A. Whittaker, John S. Condeelis and Jeffrey W. Pollard J Immunol cites 69 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription http://www.jimmunol.org/content/suppl/2009/12/15/jimmunol.090236 0.DC1 This article http://www.jimmunol.org/content/184/2/702.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2010 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of October 2, 2021. The Journal of Immunology Gene Expression Analysis of Macrophages That Facilitate Tumor Invasion Supports a Role for Wnt-Signaling in Mediating Their Activity in Primary Mammary Tumors Laureen S.
    [Show full text]
  • T-, B-And NK-Lymphoid, but Not Myeloid Cells Arise from Human
    Leukemia (2007) 21, 311–319 & 2007 Nature Publishing Group All rights reserved 0887-6924/07 $30.00 www.nature.com/leu ORIGINAL ARTICLE T-, B- and NK-lymphoid, but not myeloid cells arise from human CD34 þ CD38ÀCD7 þ common lymphoid progenitors expressing lymphoid-specific genes I Hoebeke1,3, M De Smedt1, F Stolz1,4, K Pike-Overzet2, FJT Staal2, J Plum1 and G Leclercq1 1Department of Clinical Chemistry, Microbiology and Immunology, Ghent University Hospital, Ghent, Belgium and 2Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands Hematopoietic stem cells in the bone marrow (BM) give rise to share a direct common progenitor either, as CLPs were not all blood cells. According to the classic model of hematopoi- found in the fetal liver.5 Instead, fetal B and T cells would esis, the differentiation paths leading to the myeloid and develop through B/myeloid and T/myeloid intermediates. lymphoid lineages segregate early. A candidate ‘common 6 lymphoid progenitor’ (CLP) has been isolated from The first report of a human CLP came from Galy et al. who À þ CD34 þ CD38À human cord blood cells based on CD7 expres- showed that a subpopulation of adult and fetal BM Lin CD34 sion. Here, we confirm the B- and NK-differentiation potential of cells expressing the early B- and T-cell marker CD10 is not þ À þ CD34 CD38 CD7 cells and show in addition that this capable of generating monocytic, granulocytic, erythroid or population has strong capacity to differentiate into T cells. As megakaryocytic cells, but can differentiate into dendritic cells, CD34 þ CD38ÀCD7 þ cells are virtually devoid of myeloid B, T and NK cells.
    [Show full text]